
Boris Pasche/LinkedIn
Apr 25, 2025, 08:56
Boris Pasche: Karmanos Cancer Institute Adds New SPECT/CT for Cancer Care
Boris Pasche, President and CEO of the Karmanos Cancer Institute, shared a post by Karmanos Cancer Institute on LinkedIn:
“Karmanos Cancer Institute, at the forefront of pioneering theranostic techniques and FDA-approved radiopharmaceutical treatments like Pluvicto and Lutathera, recently achieved a milestone with the installation of a cutting-edge SPEC/CT machine at our Detroit cancer center. This advancement signifies a significant step towards delivering personalized, state-of-the-art care to our patients.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 25, 2025, 08:56
Apr 25, 2025, 08:46
Apr 25, 2025, 08:32
Apr 25, 2025, 07:53
Apr 25, 2025, 07:41